BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220325T080000
DTEND;TZID=America/Los_Angeles:20220325T090000
DTSTAMP:20260407T150935
CREATED:20220310T224234Z
LAST-MODIFIED:20220310T224337Z
UID:6894-1648195200-1648198800@dev.califesciences.org
SUMMARY:Halloran Town Hall: Total Data Control and Custody – Moving from Excel to Complete Integration for Better Clinical Trial Decisions
DESCRIPTION:We have certainly come a long way in clinical trial operations over the past few years as our industry collectively shifted to decentralized and hybrid models to collect patient data outside of the traditional site model. And sponsors have a lot of data. This growth\, though celebrated\, also comes with growing pains\, like figuring how to build a large data mapping infrastructure to harness the trial’s data for better insight and oversight. \nIf you’re experiencing a similar issue\, please join our Halloran-hosted virtual Town Hall on March 25\, 2022\, from 11:00a.m. – 12:00p.m. EST on “Total Data Control and Custody: Moving from Excel to Complete Integration for Better Clinical Trial Decisions” led by the global data strategy and innovation team at CSL Behring and joined by experts from Halloran. CSL Behring has recently designed a data infrastructure for their studies that allowed their teams to have better control over their data\, leading to more informed decisions. They have major lessons learned and context behind their change and will be sharing their insights with the panel (and you!) to work through the following: \nHow do you integrate data sources and automate processes to get to a point of total data control regardless of company size? \nHow to get executive buy-in around data standards and oversight? \nWhat does the planning entail? Where do we start? \nIs this the future of data? How should companies prepare? \nIf you too want to evolve in this direction\, there is significant time and money that will need to be spent well in advance of when the trial data needs to be submitted. So\, let’s brainstorm and learn from each other. We hope you can join us – and bring your questions – to talk through scenarios for better data strategy\, control\, and custody for better decision making. \nMeet the Panel: \nMeghan Powers\, Director\, Clinical Practice Operations\, Halloran Consulting Group; Karen Travers\, Associate Principal Consultant\, Organizational & Quality Solutions\, Halloran Consulting Group; Thomas Verish\, Head of Global Data Strategy & Innovation\, CSL Behring; Valerie Reynaert\, Head of Global Clinical Operations\, CSL Behring; Charles Johnson\, Director\, eClinical Operations\, CSL Behring; Tony Ciliberto\, Senior Director\, Global Clinical Operations\, CSL Behring \nRegister» \nUpon registration you will receive a calendar invite with Zoom info.
URL:https://dev.califesciences.org/event/halloran-town-hall-total-data-control-and-custody-moving-from-excel-to-complete-integration-for-better-clinical-trial-decisions/
LOCATION:Live\, Online
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220316T110000
DTEND;TZID=America/Los_Angeles:20220316T113000
DTSTAMP:20260407T150935
CREATED:20220302T234427Z
LAST-MODIFIED:20220304T001319Z
UID:6766-1647428400-1647430200@dev.califesciences.org
SUMMARY:Using STEP and SciLeads To Grow Your California Biotech Business
DESCRIPTION:Join the live webinar with Laura Haldane as she introduces SciLeads\, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads\, and develop outreach strategies. \nAlso joining Laura is Mariana Guevara from the California Governor’s Office of Business and Economic Development who will speak about how the STEP grant program can contribute toward the cost of the SciLeads database subscription. \nRegister»
URL:https://dev.califesciences.org/event/using-step-and-scileads-to-grow-your-california-biotech-business/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220315T073000
DTEND;TZID=America/Los_Angeles:20220315T170000
DTSTAMP:20260407T150935
CREATED:20220218T232315Z
LAST-MODIFIED:20220225T000143Z
UID:6502-1647329400-1647363600@dev.califesciences.org
SUMMARY:Fierce Pharma: BD&L Summit - Deal-Making Insights for the Life Sciences Industry
DESCRIPTION:Successfully identify and execute strategic partnerships\, licensing\, and M&A Deals \nThe Fierce Business Development and Licensing (BD&L) Summit for Life Sciences returns LIVE in 2022 bringing together key deal-makers and serving as an open forum for cross-functional business development\, due diligence\, finance\, and legal teams to share valuable insights and actionable strategies on successfully sourcing and evaluating new opportunities\, conducting due diligence\, and structuring licensing agreements and M&A deals. \nCLS Members receive 25% off your registration using code CALS at checkout!  \nRegister»
URL:https://dev.califesciences.org/event/bdl-summit-deal-making-insights-for-the-life-sciences-industry/
LOCATION:Hyatt Centric Fisherman’s Wharf San Francisco\, 555 North Point Street\, San Francisco\, 94133\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220309
DTEND;VALUE=DATE:20220311
DTSTAMP:20260407T150935
CREATED:20220224T234342Z
LAST-MODIFIED:20220225T163553Z
UID:6644-1646784000-1646956799@dev.califesciences.org
SUMMARY:MDMA: 2022 FDA Forum
DESCRIPTION:MDMA’s 2022 FDA Forum will feature senior officials from FDA and industry and focus on the\nkey regulatory issues impacting the medical device industry. \nDesigned specifically for medical device regulatory professionals and executive decision makers\,\nMDMA’s FDA Forum promises to deliver key regulatory insights and preview trends\nthat will impact your regulatory and business strategies. \nTopics will include: \nFDA’s Continued COVID-19 Response\nNavigating 510(k)\, De Novo\, PMA Programs\nDigital Health\nCDRH Update\nBest Practices for Pre-Submission meetings\nEmerging Issues (Biocompatibility\, Supply Chain & More)\nMDUFA Update \nThis conference is pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion \nCLS Members receive $100 off registration using code STATE at checkout.  \n  \nRegister»
URL:https://dev.califesciences.org/event/mdma-2022-fda-forum/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220222T160000
DTEND;TZID=America/Los_Angeles:20220222T180000
DTSTAMP:20260407T150935
CREATED:20220218T174339Z
LAST-MODIFIED:20220225T170324Z
UID:6479-1645545600-1645552800@dev.califesciences.org
SUMMARY:Women in Bio - SoCal Chapter Presents "Rare Disease 8: Intersecting Access & Diversity for Underserved Communities"
DESCRIPTION:Join us for a discussion on improving patient access to healthcare in under-represented communities\, the importance of diversifying clinical trials\, and exploring rare diseases that affect Black\, Indigenous\, and People of Color (BIPOC) women. \nRegister»
URL:https://dev.califesciences.org/event/women-in-bio-socal-chapter-presents-rare-disease-8-intersecting-access-diversity-for-underserved-communities/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
END:VCALENDAR